Dusseldorf - Delayed Quote EUR
CytomX Therapeutics Inc (6C1.DU)
1.8920
+0.0940
+(5.23%)
At close: May 16 at 7:31:54 PM GMT+2
Loading Chart for 6C1.DU
- Previous Close
1.7980 - Open
1.7360 - Bid 1.7840 x --
- Ask 1.8310 x --
- Day's Range
1.7360 - 1.8920 - 52 Week Range
0.3794 - 2.2660 - Volume
0 - Avg. Volume
68 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 6C1.DU
View MorePerformance Overview: 6C1.DU
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
6C1.DU
87.70%
S&P 500 (^GSPC)
1.30%
1-Year Return
6C1.DU
6.29%
S&P 500 (^GSPC)
12.48%
3-Year Return
6C1.DU
14.98%
S&P 500 (^GSPC)
48.66%
5-Year Return
6C1.DU
68.12%
S&P 500 (^GSPC)
108.07%
Compare To: 6C1.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6C1.DU
View MoreValuation Measures
As of 5/15/2025
Market Cap
143.85M
Enterprise Value
79.69M
Trailing P/E
4.19
Forward P/E
2.68
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.17
Price/Book (mrq)
6.47
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
2.37
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--